Find COVID-19 Funding Opportunities

COVID-19 Funding Opportunities by Institute

The following opportunities represent both federal and non-federal funding opportunities. The federal opportunities are also posted on the Grants.gov, NIH Guide for Grants and Contracts, and NSF.Gov.

Investigators should check eligibility and obtain any necessary approvals before applying.

Notice of Special Interest (NOSI) applies to Administrative Supplements and Revision Supplements only for Coronavirus.

Revised 5/15/2020

23 and Me

The 23andMe Research Innovation Collaborations Program pairs up academic researchers with 23andMe scientists to perform analyses. Through this program, academic researchers can access de-identified, aggregated data from the 23andMe Research Cohort. The 23andMe database is a rich resource, with genotypic and phenotypic information from more than 5 million of our customers, 80 percent of whom consent to participate in 23andMe Research. By consenting to participate, our customers agree to make their de-identified genetic data available for study in aggregate and take part in online research under a protocol approved by an external institutional review board (IRB). These research participants also answer online survey questions on a variety of topics, and to date have contributed over 2 billion phenotypic data points.

23andMe Research; Deadline: Rolling

Amazon Web (AWS)

The AWS Diagnostic Development Initiative (DDI) provides support for innovation in rapid and accurate patient testing for 2019 novel coronavirus (COVID-19), and other diagnostic solutions to mitigate future outbreaks. Although vaccine and treatment development research is generally funded by private foundations and government agencies, fast and reliable diagnostic techniques are slow to be developed. Accurate testing and diagnosis at point-of-care or regional locations for patients with COVID-19 is critical to early intervention and treatment. AWS is offering technical support and providing AWS promotional credits to support the use of AWS services to advance diagnostic research for selected institutions and companies.

AWS Diagnostic Development Initiative (DDI); Deadline: June 30, 2020 - EXPIRED

AHRQ

Announcement to Support Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19

PA20-071; Deadline: Forecasted

Novel, High Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19

RFA-HS-20-003; Deadline: LOI June 1, 2020; Application June 15, 2020 - EXPIRED

Argonne National Laboratory

Expedited, Rapid Access Call for COVID-19 Research

Deadline: July 2, 2020 - EXPIRED

APhA Foundation NEW

Residents and their preceptor may apply for an APhA Foundation Incentive Grant. A project proposal with any community/ambulatory-pharmacy based practice innovation is acceptable, but preference will be given to projects with a focus in the following areas: Behavioral Health; Diabetes/ Cardiovascular Care; Pain Management; Patient Care Workflow; Pharmacist-Patient Communication; Pharmacogenomics; COVID-19 Prevention/Treatment/Testing.

2021 Incentive Grants; Deadline: September 8, 2020

Coalition for Economic Preparedness Innovations (CEPI)

CEPI issues calls for proposals and requests for information inviting applicants to submit proposals for projects to develop vaccine candidates and support clinical trials involving vaccine candidates.

COVID-19 vaccines: Deadline: rolling call open until at least September 28, 2020 NEW

Proposals to accelerate the development of safe and effective vaccines in 12-18 months or less.

COVID-19_CFP_2C; Deadline: June 30, 2020 EXPIRED

CHEST Foundation NEW

As the charitable foundation for the American College of Chest Physicians, the CHEST Foundation has a mission of championing lung health by supporting clinical research, patient education and community service. An important resource for young investigators seeking research funding. Applications must address clinical (hospital or outpatient) or community-related aspects of COVID-19.

Research Grant in COVID-19: Deadline: August 7, 2020

The American Thoracic Society and its Research Program are improving respiratory health worldwide by supporting young investigators in pulmonary, critical care, and sleep medicine. Applications must address clinical (hospital or outpatient) or community-related aspects of COVID-19 that focus on an underrepresented minority (URM) patient group.

CHEST Foundation and the American Thoracic Society Research Grant in COVID-19 and Diversity; Deadline: August 7. 2020

DHHS

Novel RNAs in Virology (including HIV) and Immune Regulation: Basic Science and Therapeutic Discovery (R21 Clinical Trial Not Allowed)

PA-19-237; Deadline: June 16, 2020 EXPIRED

Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)

PAR-20-155; Deadline: Standard Dates apply

Office of Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)

BARDABAA; Deadline: White Paper submission deadlines are at the end of every month. The final White Paper submission deadline is October 31, 2020; Applications due 10/31/2020.

Bench Testing Therapeutic/Indication Pairing Strategies;. This Funding Opportunity Announcement (FOA) invites applications for support of pre-clinical studies to repurpose existing experimental or FDA approved drugs or biologics (existing therapeutics) that have already begun or completed at least a Phase l trial. The hypothesis for proposed studies must be developed using innovative processes to identify the therapeutic/indication pair.

PAR-17-465; Deadline: June 26, 2020; October 30, 2020

DOD

CDMRP PRMRP Investigator-Initiated Research Award for Emerging Viral Diseases and Respiratory Health

W81XWH-20-PRMRP-IIRA-COV; Deadline: June 12, 2020 EXPIRED

CDMRP PRMRP Technology/Therapeutic Development Award for Emerging Viral Diseases and Respiratory Health

W81XWH-20-PRMRP-TTDA-COV; Deadline: June 12, 2020 EXPIRED

CDMRP PRMRP Clinical Trial Award for Emerging Viral Diseases and Respiratory Health

W81XWH-20-PRMRP-CTA-COV; Deadline: June 22, 2020 EXPIRED

Emergency Medicine Foundation

The Emergency Medicine Foundation is awarding funding of up to $100,000 in new research grants on emergency medicine areas related to COVID-19.

Request for Proposal; Grant requests can range from $10,000 to $50,000; Deadline: June 5, 2020 EXPIRED

Encephalitis and COVID-19 Seed Funding NEW

This funding is open to applicants worldwide and to all levels from medical students, junior doctors and early researchers, those returning to research to post-doctoral research or equivalent professional experience. Looking for anyone who wants to develop compelling and innovative ideas which look at encephalitis and COVID-19, anything from diagnosis and treatment through to recovery and rehabilitation.

Request for Proposal; Deadline: August 31, 2020

Facebook

Economic Impact of Digital Technologies Request for Proposals; Deadline: May 20, 2020 EXPIRED

Facebook is issuing a call for academic research proposals as part of its pledge to contribute $1 million to research that addresses the economic impact of digital technologies, including new tools that enable commercial opportunities.

IBM; IBM X Prize

Build a coding solution that can provide immediate crisis communication, enhanced remote education, or stronger community cooperation.

2020 COVID-19 Call for Code Global Challenge; Deadline: 7/31/2020

Indo-US Science & Technology Forum (IUSSTF) Each proposals must include one institution from India and one from the U.S.

Call for Proposals; Deadline: 5/15/2020

IBM & National Science Foundation: COVID-19 High Performance Computing Consortium NEW

COVID-19 HPC Consortium; Deadline: Rolling

InnoCentive

Ideation Challenge: What Should We Know to Better Treat Coronavirus Deadline: May 24, 2020 EXPIRED

This Challenge is asking InnoCentive Solvers to formulate well-defined problems aimed at advancing our knowledge about Coronavirus. One could think of this as what might we have known that would have allowed us to respond more effectively against COVID-19.

Challenge: Looking for a film to provent infection

The Challenge is looking for a thin film that, when applied to hands and other open parts of the human body, would prevent people from being infected with the COVID-19 virus.

Anti-COVID-19 Infection Protective Film; Deadline: June 15, 2020 EXPIRED

Ideation Challenge: Gamification to Prevent the Spread of Coronavirus

Gamification has been long recognized as a powerful approach to changing social behavior, including health related behavior. The objective of this challenge is to apply gamification to changing people's social behavior to prevent the spread of Coronavirus and other infections.

Gamification to Prevent the Spread of Coronavirus; Deadline: June 12, 2020 EXPIRED

Institute for Global Health

The Institute for Global Health is pleased to share this call for applications to supporting member faculty COVID-19 projects, including, but not limited to, events, education, community engagement, or implementation projects. These funds are not intended to support research projects. Those interested in research awards should apply for COVID-19 Research Catalyzer Funding for Faculty.

COVID-19 Global Health Projects; Deadline: Immediately and up to June 1, 2020 EXPIRED

Internet Society Foundation

Our Emergency Response Programme will provide funding to organizations working on projects that utilize the Internet to improve lives during or in response to an emergency situation. In 2020, the Foundation’s focus will be on projects that respond to the COVID-19 pandemic, both during the immediate period of the crisis but also looking ahead at responses to the inevitable “second wave” later this year/into 2021.

2020 Focus: Coronavirus and COVID-19; Deadline: 5/17/2020 EXPIRED

Jacob and Valeria Langeloth Foundation

The CRRF was put in place to enable Langeloth to address organizations’ urgent and critical needs that have arisen due to the COVID-19 global pandemic.

COVID-19 Rapid Response Fund; Deadline: Rolling

Kaggle

COVID-19 Open Research Dataset Challenge (CORD-19)

Merck KGaA (Germany)

The threat from newly emerging viral infections is one of the top global challenges for humanity. The recent COVID-19 pandemic shows that pandemic preparedness and having the right products and technology to fight infectious diseases with epidemic and pandemic potential is of utmost importance. It is required to act quickly to limit further substantial damages to society, economy and ecology.

Research Grant for Pandemic Preparedness; Deadline: Rolling

Mozilla/Moss

COVID-19 Solutions Funds; Deadline: Rolling

NIH

Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) (NIH)

NOT-HL-20-757; Deadline: Applications accepted on a rolling basis through October 6, 2020

Emergency Awards: RADx_UP Coordination and Data Collection Center (CDCC) (U24 Clinical Trial Optional)

RFA-OD-20-013; Deadline: LOI - July 8, 2020; Application deadline - August 7, 2020

NCCIH

Notice of Special Interest (NOSI): Availability of Administrative Supplements and Urgent Competitive Revisions for Research on Stress Management in Relation to Coronavirus Disease 2019 (COVID-19) (NCCIH, NIA, NIAAA)

NOT-AT-20-011; Deadline: Applications accepted on a rolling basis through October 6, 2020

Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences (OBSSR, NHLBI, NIA, NIAAA, NIDDK, NIEHS, NCCIH, NCI)

NOT-OD-20-097; Deadline: Applications accepted on a rolling basis through March 31, 2021

NCI

Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional) (NIMHD, NIA, NIDA, NCI)

PA-20-172; Deadline: Letter of Intent - 9/4/2020; Application - 10/5/2020

NOT-OD-20-097; Deadline: Applications accepted on a rolling basis through March 31, 2021

NHGRI

Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (NHGRI)

NOT-HG-20-030; Deadline: Applications accepted on a rolling basis through May 15, 2020

NHLBI

NOT-OD-20-097; Deadline: Applications accepted on a rolling basis through March 31, 2021

NIA

Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional) (NIMHD, NIA, NIDA, NCI)

PA-20-172; Deadline: Letter of Intent - 9/4/2020; Application - 10/5/2020

NOT-AT-20-011; Deadline: Applications accepted on a rolling basis through October 6, 2020

Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) (NIA, NIMH)

NOT-AG-20-022; Deadline: Applications accepted on a rolling basis through May 1, 2021

NOT-OD-20-097; Deadline: Applications accepted on a rolling basis through March 31, 2021

NIAAA

NOT-AT-20-011; Deadline: Applications accepted on a rolling basis through October 6, 2020

NOT-OD-20-097; Deadline: Applications will be accepted on a rolling basis, beginning on 04/30/2020 NEW

NIAID

Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (NIAID)

NOT-AI-20-034; Deadline: Applications accepted on a rolling basis through March 25, 2021

Notice of Special Interest (NOSI): Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (NIAID)

NOT-AI-20-031; Deadline: Applications accepted on a rolling basis through April 5, 2021

Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed)

PAR-20-178; R01 - Deadline: Applications accepted on a rolling basis through April 5, 2021

NEW Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed). The purpose of this public health emergency funding opportunity is to provide Personal Protective Equipment (PPE) to directly support the needs of the NIAID's vaccine and treatment clinical trials and clinical studies for COVID-19. This program will ensure that adequate protective PPE is available to directly assist in safely carrying out the clinical activities and direct interactions with patients participating in the trial.

PAR-20-256; Deadline: Rolling

Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed)

PAR-20-177; R21 - Deadline: Applications accepted on a rolling basis through April 5, 2021

NIBIB

NEW: Fast-Track Program for COVID-19 Test Development and Distribution; Innovative Technologies to Increase U.S. Capacity for COVID-19 Testing. NIBIB is providing substantial support to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to clinical laboratory tests, that can directly detect SARS-CoV-2, the virus that causes COVID-19. NIBIB will support the full range of product development including commercialization and product distribution.

Rapid Acceleration of Diagnostics (RADx); Deadline: Rolling

Notice of Special Interest (NOSI): Availability of Emergency Competitive Revision and Administrative Supplements on Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) (NIBIB)

NOT-EB-20-008; Deadline: Applications accepted on a rolling basis through November 20, 2020

NIDA

Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional) (NIMHD, NIA, NIDA, NCI)

PA-20-172; Deadline: Letter of Intent - 9/4/2020; Application - 10/5/2020

NOT-DA-20-047; Deadline: Applications accepted on a rolling basis through March 31, 2021

NIDDK

Mechanistic Studies of the Interaction between SARS-Co-V-2/COVID-19 and DIseases and Organ Systems of Interest to NIDDK (RO1 Clinical Trial Optional). This funding opportunity is to support basic and clinical mechanistic research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) susceptibility, routes of infection, course of disease, morbidity and mortality in people with pre-existing diseases, or adverse acute or chronic outcomes in organs, tissues and biological systems of special interest to NIDDK. These include diabetes and other metabolic diseases, obesity, and endocrine, digestive, liver, pancreas, kidney, urological and hematologic tissues and diseases.

RFA-DK-20-021; Letter of Intent (LOI): November 16, 2020; Deadline: December 16, 2020 NEW

NOT-OD-20-097; Deadline: Applications accepted on a rolling basis through March 31, 2021

NIEHS

Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) (NIEHS)

NOT-ES-20-015; Deadline: Applications accepted on a rolling basis through May 3, 2021

NOT-OD-20-097; Deadline: Applications accepted on a rolling basis through March 31, 2021

Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) (NIEHS)

NOT-ES-20-020; Deadline: Applications accepted from May 1, 2020 through May 3, 2021

NOT-OD-20-097; Deadline: Applications accepted on a rolling basis through March 31, 2021

NIGMS

Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 (NIGMS)

NOT-GM-20-025; Deadline: Applications accepted on a rolling basis through February 5, 2021

Notice of Special Interest (NOSI): Availability of Urgent Award for Competitive Revisions to IDeA-CTR Awards to Address the Need for Documenting 2019 Novel Coronavirus Disease (COVID-19) -Related Patient Outcomes

NOT-GM-20-033; Deadline: June 18, 2020

NIMH

Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus (NIMH)

NOT-MH-20-047; Deadline: Applications accepted on a rolling basis through April 15, 2021

Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) (NIA, NIMH)

NOT-AG-20-022; Deadline: Applications accepted on a rolling basis through May 1, 2021

NIMHD

Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional) (NIMHD, NIA, NIDA, NCI)

PA-20-172; Deadline: Letter of Intent - 9/4/2020; Application - 10/5/2020

Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID- 19 Outbreak on Minority Health and Health Disparities (NIMHD)

NOT-MD-20-019; Deadline: Applications accepted on a rolling deadline from May 1, 2020 - May 1, 2021

Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIDDK (NIDDK)

NOT-DK-20-018; Deadline: June 1, 2020 EXPIRED

Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) Related to HIV Co-morbidities, Co-infections, and Complications within NIDDK's Mission (NIDDK)

NOT-DK-20-020; Deadline: June 1, 2020 EXPIRED

Notice of Special Interest (NOSI): Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) (NIBIB)

NOT-EB-20-007; Deadline: June 5, 2020 and June 16, 2020 EXPIRED

Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) (NCATS)

NOT-TR-20-012; Deadline: June 5, 2020 through October 16, 2020

Partnerships for Countermeasures against Select Pathogens

RFA-AI-20-028; Deadline: June 29, 2020

Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms

PAR-18-781; Deadline: September 9, 2020

NSF

Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19)

Through this DCL, the Office of Advanced Cyberinfrastructure (OAC) within the Directorate for Computer and Information Science and Engineering is inviting RAPID proposals and supplemental funding requests to existing awards that address COVID-19 challenges through data and or software infrastructure development activities.

NSF-20-052; Deadline: Rolling NEW

Ecology and Evolution of Infectious Diseases (EEID) - The multi-agency Ecology and Evolution of Infectious Diseases program supports research on the ecological, evolutionary, and social drivers that influence the transmission dynamics of infectious diseases.

NSF 19-592; Deadline: November 18, 2020

IBM & National Science Foundation: COVID-19 High Performance Computing Consortium NEW

COVID-19 HPC Consortium; Deadline: Rolling

The Patient-Centered Outcomes Research Institute (PCORI)

The Eugene Washington PCORI Engagement Awards support projects that encourage active integration of patients, caregivers, clinicians, and other healthcare stakeholders as integral members of the patient-centered outcomes research/comparative clinical effectiveness research (PCOR/CER) enterprise.

Supporting Engagement in and Dissemination of PCOR/CER in the Context of COVID-19; Deadline: 5/22/2020 EXPIRED

North Carolina Biotechnology Center NEW

NCBiotech's Flash Grant Program aims to identify and energize the most creative ideas that exhibit early indications of commercial potential. Flash Grants are used to demonstrate the disruptive potential of a technology or to move a technology into the translational research phase of development. Cycle 1: Novel antibiotics and therapeutics targeting antibiotic-resistant bacteria and Global Coronavirus disease (COVID-19) outbreak - specific therapies, vaccine development, diagnosis and epidemiology

Cycle 1: Deadline: August 12, 2020 - NOON; Maximum Award $20,000

Patient- Centered Outcomes Research Institute (PCORI)

A total of up to $20 million will go toward funding award increases for research and other projects related to the response. It will also address appropriate changes caused by the COVID-19 emergency. For instance, some researchers may revise their plans by adding coronavirus aims to their studies or switching to virtual environments.

PCORI New Research Studies, Implementation and Engagement Projects COVID-19 commitment

Pfizer

During this challenging time, Pfizer is committed to doing all we can to respond to the COVID-19 pandemic. We recognize the need for the rapid development of educational programs and trainings and the implementation of systemic best practices for COVID19 management. As part of our commitment, we are releasing this Request for Proposals (RFP) to provide financial support for organizations producing independent educational programs and quality improvement initiatives designed to combat this evolving crisis.

COVID-19 Competitive Grant Program; Deadline: 5/21/2020

Robert Wood Johnson Foundation

As our current reality underscores, we live in a dynamic world—where unforeseen global events; new technologies; scientific discoveries; changes in our climate, economy, demographics; and more—continually shape where and how we live, learn, work and play. These changes will profoundly impact health equity in our society, from our individual health and the health of our families to the health of our communities.

Pioneering Ideas: Exploring the Future to Build a Culture of Health; Deadline: rolling

The need to identify successful system alignment strategies has become increasingly urgent in the wake of the SARS-CoV-2 virus pandemic that causes COVID-19. This call for proposal will provide supplemental research funding to teams that are already engaged in the study of promising system alignment mechanisms with the objective of learning how this mechanism performs in addressing health and social needs during the COVID-19 pandemic.

Supplemental Research on COVID-19 Response and Recovery; Deadline: August 5, 2020

Russell Sage Foundation

All Letter of Inquiry (LOI) must focus on issues related to the Foundation’s core program areas and special initiatives: Behavioral Economics; Decision-Making and Human Behavior in Context; Future of Work: Race, Ethnicity, and Immigration; Social, Political and Economic Inequality.

Funding Opportunities; Deadline: LOI due May 21, 2020; Application due August 5, 2020

Social Science Research Council

As part of its Just Tech program, SSRC seeks proposals from across the social sciences and related fields that address the risks, opportunities and challenges posed by public health surveillance stemming from the Covid-19 pandemic.

Just Tech Covid-19 Rapid Response Grants; Deadline: 8/31/2020 NEW

In partnership with the Henry Luce Foundation, The Social Science Research Council (SSRC), as part of its Covid-19 Initiative, seeks proposals from across the social sciences and related fields that address the social, economic, cultural, psychological, and political impact of Covid-19 in the United States and globally, as well as responses to the pandemic’s wide-ranging effects.

Rapid Response Grants on COVID-19 and the Social Sciences; Deadline: June 1, 2020

SURF

Given the urgency and overall public importance of COVID-19 research, NWO and SURF launch a COVID-19 Fast Track as part of this Compute Call.

COVID-19 Fast Track for Computing Time; Deadline: June 30, 2020

Wellcome Trust in partnership with the Bill & Melinda Gates Foundation and Mastercard

The COVID-19 Therapeutics Accelerator